Answers are grounded in this paper and cite their sources.
fragments, or with intravenous immunoglobulin (IVIg). These data suggest the existence of an ITAMi-mediated mechanism by which LAP might protect against inflammation. Sustaining LAP may open therapeutic perspectives for patients with chronic liver disease.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: